Church & Dwight (CHD) Q3 2025: Touchland Drives +8.4% International Growth, Offsetting U.S. Mix Headwinds

Touchland’s breakout performance and robust international growth countered U.S. price mix pressure in Q3, as Church & Dwight leaned into value and premium innovation across its portfolio. Management’s focus on targeted marketing, disciplined promotion, and portfolio optimization shapes a resilient outlook into 2026, with ongoing vitamin business review and active M&A posture signaling further strategic evolution.

Summary

  • International Acceleration: Overseas sales momentum, led by Touchland and Hero, outpaced domestic trends.
  • Value and Premium Barbell: Arm & Hammer’s value strength and TheraBreath’s premium growth both gained share.
  • Portfolio Shaping Ahead: Vitamin business review and M&A focus will drive Church & Dwight’s next phase.

Performance Analysis

Church & Dwight’s Q3 2025 results highlighted a resilient business model that capitalizes on both value and premium consumer trends. Organic sales grew 3.4%, driven by 4% volume growth and partially offset by negative price/mix, reflecting consumers’ shift toward larger pack sizes and ongoing pricing adjustments in vitamins and Batiste. The U.S. consumer business delivered 2.3% organic growth, led by TheraBreath, Hero, Arm & Hammer, and Trojan, while international operations surged 8.4%, with Touchland and Hero as standouts. SBD (Specialty Brands Division) posted a 4.2% organic increase, benefitting from price, mix, and volume improvements.

Gross margin expanded 10 basis points year-over-year, despite 200 basis points of inflation and tariff headwinds, as productivity programs and higher-margin acquisitions offset cost pressures. Marketing investment increased to 12.8% of sales, reflecting a commitment to brand support. Cash flow from operations jumped nearly 20% to $435.5 million, and the company executed $300 million in share buybacks during the quarter.

  • Touchland Outperformance: The hand sanitizer brand exceeded expectations, with double-digit consumption growth and strong retailer velocity, highlighting the success of recent M&A integration.
  • Value Tier Resurgence: Arm & Hammer laundry’s household penetration reached a record 30%, as value brands captured share amid consumer trade-down behavior.
  • Negative Price Mix Drivers: Larger pack sizes, targeted price reductions in vitamins and Batiste, and channel mix shifts contributed to negative price/mix, even as volume remained robust.

Despite a challenging consumer backdrop and heightened promotional activity in certain categories, Church & Dwight’s diversified portfolio and disciplined execution delivered broad-based share gains. The company’s ability to balance value and premium offerings positions it well for continued outperformance relative to category growth.

Executive Commentary

"Our portfolio, with its balance of value and premium offerings, continue to gain both dollar and volume share. Our innovation is performing well, and all in all, our brands are made for environments like this."

Rick Dierker, President and Chief Executive Officer

"Our third quarter adjusted gross margin was 45.1%, a 10 basis point increase from a year ago, and 110 basis points better than our outlook. These factors offset 200 basis points of inflation and tariff costs."

Lee McChesney, Executive Vice President and Chief Financial Officer

Strategic Positioning

1. Value and Premium Barbell Drives Share Gains

Church & Dwight’s portfolio is uniquely positioned across the value-premium spectrum. Arm & Hammer’s value proposition resonated with cost-conscious consumers, growing household penetration and share with minimal promotional escalation. Simultaneously, premium brands like TheraBreath and Hero delivered double-digit consumption growth, fueled by innovation and effective marketing. This dual focus enables the company to capture shifting consumer preferences in a volatile environment.

2. Innovation Pipeline and Marketing Investment

New product launches remain central to Church & Dwight’s growth strategy. The company highlighted upcoming innovations such as TheraBreath toothpaste and Trojan Goat non-latex condoms, targeting unmet consumer needs. Elevated marketing spend (above 11% of sales) underpins category leadership and supports long-term brand equity, even as management remains disciplined on promotional spending and couponing relative to peers.

3. International Expansion and Touchland Integration

International sales growth outpaced the U.S., with Touchland, Hero, and TheraBreath driving momentum across multiple markets. The Touchland acquisition, focused on prestige retail channels like Sephora, Ulta, and Amazon, is being scaled internationally with a selective distribution approach to maintain brand cachet. This international strategy leverages problem-solution brands with low household penetration, offering substantial runway for growth.

4. Portfolio Optimization and Vitamin Business Review

Church & Dwight is actively reviewing its vitamin business, considering supply chain streamlining, joint ventures, or divestiture. Management cited “green shoots” in core SKUs and distribution gains, but acknowledged ongoing consumption declines. The outcome of this review, expected by the end of 2025, will further align the portfolio with higher-growth, higher-margin categories.

5. Disciplined Capital Allocation and M&A Focus

Capital deployment remains balanced between M&A and opportunistic share buybacks. The company repurchased $600 million in shares year-to-date while maintaining “M&A as the number one focus” for cash. Management’s upgraded balance sheet and strong cash flow provide flexibility for future acquisitions, particularly in functional beauty and personal care adjacencies.

Key Considerations

This quarter underscores Church & Dwight’s ability to navigate a mixed macro and consumer landscape by leveraging its diversified brand portfolio, disciplined execution, and targeted investments in innovation and marketing.

Key Considerations:

  • Touchland Integration Momentum: The acquisition’s early outperformance provides incremental growth and margin tailwind, with further international expansion planned.
  • Value Tier Resilience Amid Trade-Down: Arm & Hammer’s leadership in the value segment is reinforced by lower promotional intensity and record household penetration.
  • Innovation as Growth Lever: New launches in oral care and sexual wellness reinforce Church & Dwight’s problem-solution brand strategy, sustaining share gains.
  • Vitamin Business Uncertainty: The ongoing review introduces near-term margin and revenue uncertainty but offers potential for portfolio simplification and improved focus.
  • Elevated Marketing Commitment: Increased brand investment supports long-term equity but may pressure near-term margins as the company offsets inflation and tariffs.

Risks

Risks center on competitive promotional intensity in core categories, ongoing negative price/mix from larger pack sizes and channel shifts, and the uncertain outcome of the vitamin business review. Macroeconomic volatility, inflation, and tariff costs remain persistent headwinds, while execution missteps in international expansion or M&A integration could disrupt momentum. Management’s guidance assumes stable category growth and continued operational discipline.

Forward Outlook

For Q4 2025, Church & Dwight guided to:

  • Reported sales growth of approximately 3.5%
  • Organic sales growth of approximately 1.5%
  • Adjusted EPS of $0.83, up 8% YoY

For full-year 2025, management raised guidance:

  • Adjusted EPS of $3.49 (up $0.02 from prior outlook)
  • Reported sales growth of approximately 1.5%
  • Organic sales growth of approximately 1%
  • Cash flow from operations outlook increased to $1.2 billion

Management cited Touchland’s momentum, productivity gains offsetting inflation and tariffs, and increased marketing investment as key drivers. Discontinued businesses are expected to create a 200 basis point sales drag in Q4, with vitamin business headwinds and port strike comps impacting near-term results.

  • Touchland baseline strengthens 2026 setup
  • Vitamin review outcome a critical watchpoint

Takeaways

Church & Dwight’s Q3 performance demonstrates the strength of a portfolio balanced between value and premium, supported by disciplined execution and targeted innovation.

  • International and M&A Upside: Touchland’s rapid integration and international growth provide a template for future bolt-on acquisitions and margin expansion.
  • Value Leadership Defends Share: Arm & Hammer’s resilience in the value tier, coupled with measured promotional activity, positions Church & Dwight to capture consumer trade-down trends without sacrificing margin.
  • 2026 Watchpoints: Investors should monitor the vitamin business outcome, continued international expansion, and the impact of elevated marketing spend on both near-term profitability and long-term share gains.

Conclusion

Church & Dwight’s Q3 2025 results reinforce its strategic agility and portfolio resilience, with Touchland’s outperformance and international strength offsetting domestic price mix headwinds. Active portfolio management, disciplined capital allocation, and a robust innovation pipeline position the company for sustained outperformance in a dynamic consumer environment.

Industry Read-Through

Church & Dwight’s results highlight several key trends for the household and personal care sector. The sustained shift toward value brands amid consumer trade-down is evident in laundry and litter, while premium “problem-solution” brands with low household penetration, like TheraBreath and Hero, continue to outperform. Elevated marketing investment is becoming table stakes for defending and expanding share, especially as promotional intensity rises. The success of targeted M&A and disciplined channel strategy (e.g., Touchland’s prestige focus) offers a roadmap for peers seeking both growth and margin. Finally, ongoing portfolio reviews and category pruning signal that large CPGs will continue to reshape their brand sets to align with evolving consumer preferences and cost realities.